Waters Corporation (WAT) Financials
WAT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 4.6 billion | 3.5 billion |
2023-09-30 | 4.5 billion | 3.6 billion |
2023-06-30 | 4.5 billion | 3.8 billion |
2023-03-31 | 3.3 billion | 2.7 billion |
WAT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 188.5 million | -60.8 million |
2023-09-30 | 119.8 million | 8.5 million |
2023-06-30 | -28.5 million | 10.9 million |
2023-03-31 | 162.4 million | 12.8 million |
WAT Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 216.2 million |
2023-09-30 | 134.6 million |
2023-06-30 | 150.6 million |
2023-03-31 | 140.9 million |
WAT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 396.0 million | - | 86.8 million |
2023-09-30 | 337.3 million | 2.5 billion | 86.7 million |
2023-06-30 | 330.6 million | 2.6 billion | 92.8 million |
2023-03-31 | 487.0 million | 1.4 billion | 86.7 million |
WAT Shares Outstanding
WAT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 41.6 million | 44.4 million | 180.4 million | - |
2023-09-30 | 38.0 million | 42.0 million | 186.7 million | - |
2023-06-30 | 46.6 million | 45.9 million | 187.0 million | - |
2023-03-31 | 34.4 million | 42.7 million | 182.0 million | - |
WAT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 819.5 million | 330.5 million |
2023-09-30 | 711.7 million | 291.4 million |
2023-06-30 | 740.6 million | 301.1 million |
2023-03-31 | 684.7 million | 284.4 million |
WAT
Price: $326.06
52 week price:
Earnings Per Share: 10.85 USD
P/E Ratio: 29.61
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 305400
Ebitda: 257.9 millionMarket Capitalization: 19.9 billion